Arrowhead Pharmaceuticals Inc. logo

Arrowhead Pharmaceuticals Inc.

ARWR | NASDAQ
Chart Builder DCF Calculator
$68.79
+$2.31 (+3.47%)
At close: Sep 21, 2026, 4:00 PM ET
$69.52
+$0.73 (+1.06%)
Pre-market: Sep 22, 2026, 5:18 AM ET

Market Data

Market Cap
$9.36B
Enterprise Value
$8.95B
Beta
1.28
Average Volume
1.89M
Shares Outstanding (Diluted)
143.38M
Shares Change YoY
3.12%
Institutional Ownership
84.84%
Exchange
NASDAQ
ISIN
US04280A1007

Price Performance

Price Change 1M
-20.7%
Price Change 3M
-13.9%
Price Change 6M
13.2%
Price Change YTD
1.5%
Price Change 1Y
114.6%
Price Change 3Y
152.5%
Price Change 5Y
5.2%
1M CAGR (ann.)
-22.5%
1Y CAGR (ann.)
128.2%
5Y CAGR (ann.)
0.8%
All-Time CAGR
1.4%

Valuation

PE Ratio
-30.71
Forward PE
N/A
PEG Ratio
0.00
Forward PEG
-0.95
PS Ratio
14.47
Forward PS
28.20
PB Ratio
20.81
P/FCF Ratio
-129.00
P/Adj. FCF Ratio
-66.77
P/OCF Ratio
-167.78
EV/Sales
13.37
EV/EBIT
-56.13
EV/EBITDA
-63.79
EV/FCF
-119.18
Earnings Yield
-3.3%
FCF Yield
-0.8%
Adj. FCF Yield
-1.5%

Financial Health

Net Cash
$737.89M
Total Debt
$864.07M
Cash & Short-Term Investments
$1.6B
Total Assets
$2.11B
Current Ratio
5.90
Quick Ratio
5.90
Debt / Equity Ratio
1.86
Debt / EBITDA
-6.16
Debt / FCF
-11.50
OCF / Debt
-0.07
Interest Coverage
-2.45
Altman Z-Score
3.00
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-33.8%
EBITDA Margin
-21.0%
Net Profit Margin
-47.8%
FCF Margin
-11.2%
Adj. FCF Margin
-21.7%
SBC / Revenue
10.5%
SBC Impact (per share)
-93.2%

Returns

Return on Assets
-15.2%
Return on Equity
-60.5%
Return on Invested Capital
-12.1%
Return on Capital Employed
-12.4%
Return on Tangible Assets
-15.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
37.7%
Revenue CAGR 5Y
44.1%
Revenue CAGR 10Y
128.7%
EPS CAGR 3Y
44.3%
EPS CAGR 5Y
-5.0%
EPS CAGR 10Y
-21.8%
FCF CAGR 3Y
109.7%
FCF CAGR 5Y
19.0%
FCF CAGR 10Y
-29.2%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
22
EPS Growth Next 3Y
22.3%
Revenue Growth Next 3Y
19.7%
Earnings Date
Nov 23, 2026
EPS Estimate (next Q)
-$1.59
EPS Growth Est (next Q)
783.3%
Revenue Est (next Q)
$59.43M
Revenue Growth Est (next Q)
-76.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$104.43
Price Target Upside
51.8%

Cash Flow

Operating Cash Flow
$-59.06M
Free Cash Flow
$-75.11M
Adj. Free Cash Flow
$-145.11M
FCF Per Share
-$0.52
OCF Per Share
-$0.41
OCF/S Ratio
-8.8%

Income Statement

Revenue
$669.5M
Gross Profit
$669.5M
Operating Income
$-226.44M
EBITDA
$-140.33M
Net Income
$-319.95M
EPS (Diluted)
-$2.24
Revenue / Employee
$941.62K
Profit / Employee
$-450K
Employees
711

© 2026 bestshares.com. All rights reserved.